The USP28‐targeting small molecule CT1113 exhibits anti‐cancer activity by destabilizing oncogenic NOTCH1 and suppressing SREBP1‐mediated lipogenesis in T‐cell acute lymphoblastic leukemia [35]. This evidence concerns the gene SREBF1 and cancer.